ChiCTR2300078094 版本V1.0 版本创建时间2023/11/28 16:36:04 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300078094 

最近更新日期:

Date of Last Refreshed on:

2023-11-28 16:34:48 

注册时间:

Date of Registration:

2023-11-28 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于心房颤动患者服务需求的中医综合康复模式构建与应用

Public title:

Construction and application of traditional Chinese medicine (TCM) comprehensive rehabilitation model based on the service needs of patients with atrial fibrillation

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于心房颤动患者服务需求的中医综合康复模式构建与应用

Scientific title:

Construction and application of traditional Chinese medicine (TCM) comprehensive rehabilitation model based on the service needs of patients with atrial fibrillation

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王承烁 

研究负责人:

赵冬琰 

Applicant:

Wang Chengshuo 

Study leader:

Zhao Dongyan 

申请注册联系人电话:

Applicant telephone:

+86 131 4152 3539

研究负责人电话:

Study leader's telephone:

+86 152 1072 2951

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangchengshuo0302@163.com

研究负责人电子邮件:

Study leader's E-mail:

zhaodongyan1230@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市昌平区小汤山镇温泉街390号

研究负责人通讯地址:

北京市昌平区小汤山镇温泉街390号

Applicant address:

390 Wenquan Street, Xiaotangshan Town, Changping District, Beijing

Study leader's address:

390 Wenquan Street, Xiaotangshan Town, Changping District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

天津体育学院

Applicant's institution:

Tianjin University of Sport

研究负责人所在单位:

北京小汤山医院

Affiliation of the Leader:

Beijing Xiaotangshan Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2023]伦审第(49)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京小汤山医院医学伦理审查委员会

Name of the ethic committee:

Medical Ethics Review Committee of Beijing Xiaotangshan Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2023-11-07 00:00:00

伦理委员会联系人:

李佳航

Contact Name of the ethic committee:

Li Jianghang

伦理委员会联系地址:

北京市昌平区小汤山镇北京小汤山医院

Contact Address of the ethic committee:

Beijing Xiaotangshan Hospital, Xiaotangshan Town, Changping District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 10 6178 9598

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京小汤山医院

Primary sponsor:

Beijing Xiaotangshan Hospital

研究实施负责(组长)单位地址:

北京市昌平区小汤山镇温泉街390号

Primary sponsor's address:

390 Wenquan Street, Xiaotangshan Town, Changping District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京小汤山医院

具体地址:

北京市昌平区小汤山镇温泉街390号

Institution
hospital:

Beijing Xiaotangshan Hospital

Address:

390 Wenquan Street, Xiaotangshan Town, Changping District, Beijing

经费或物资来源:

北京市中医药科技发展资金项目(BJZYYB-2023-23)

Source(s) of funding:

Beijing Traditional Chinese Medicine Science and Technology Development Fund Project (BJZYYB-2023-23)

Target disease:

atrial fibrillation

Target disease code:

研究类型:

治疗研究

Study type:

Treatment study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

单臂 

Study design:

Single arm 

研究目的:

1.调查北京市心房颤动患者中医康复需求与意愿现状,分析相关影响因素; 2.初步构建适合心房颤动患者的中医综合康复模式; 3.应用中医综合康复模式对心房颤动患者进行干预,评价应用效果。  

Objectives of Study:

1. To investigate the current situation of the needs and willingness of TCM rehabilitation in patients with atrial fibrillation in Beijing, and analyze the related influencing factors; 2. Initially construct a comprehensive TCM rehabilitation model suitable for patients with atrial fibrillation; 3. To apply comprehensive rehabilitation mode of traditional Chinese medicine (TCM) to patients with atrial fibrillation, and evaluate the application effect.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)40岁≤年龄≤80岁,性别不限; (2)符合房颤诊断标准的非瓣膜性房颤; (3)意识清楚,愿意进行中医综合康复治疗,能配合此次研究; (4)研究参与者知情,并签署知情同意书。

Inclusion criteria

(1) 40 years old ≤ age ≤80 years old, regardless of gender; (2) non-valvular AF meeting the diagnostic criteria for AF; (3) clear awareness, willing to carry out comprehensive TCM rehabilitation treatment, and able to cooperate with this study; (4) Informed consent was obtained from all participants.(1)40≤≤80,;

排除标准:

(1)合并有精神疾患而无法合作或不能配合治疗; (2)恶性心律失常、急性左心衰、急性心肌梗死等急危重症; (3)研究者认为不适合入选的其他情况。

Exclusion criteria:

(1) comorbid mental disorders that prevent cooperation or treatment; (2) malignant arrhythmia, acute left heart failure, acute myocardial infarction and other critical diseases; (3) other conditions considered by the investigators to be unsuitable for inclusion.

研究实施时间:

Study execute time:

From 2023-09-01 00:00:00 To 2025-08-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-12-01 00:00:00 To 2025-08-31 00:00:00  

干预措施:

Interventions:

组别:

心房颤动组

样本量:

25

Group:

The Atrial FIBRILLATION GROUP

Sample size:

干预措施:

中医综合康复

干预措施代码:

Intervention:

Comprehensive rehabilitation of traditional Chinese medicine

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China 

Province:

Beijing 

City:

 

单位(医院):

北京小汤山医院 

单位级别:

三级 

Institution
hospital:

Beijing Xiaotangshan Hospital

Level of the institution:

Tertiary

测量指标:

Outcomes:

指标中文名:

房颤/房扑百分比

指标类型:

主要指标

Outcome:

Percentage of atrial fibrillation/atrial flutter

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

SDNN-24小时

指标类型:

主要指标

Outcome:

SDNN-24 hours

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

rMSDNN

指标类型:

主要指标

Outcome:

rMSDNN

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

频域功率

指标类型:

主要指标

Outcome:

Frequency domain power

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

左房(室)内径

指标类型:

次要指标

Outcome:

Left atrial (ventricular) diameter

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

左房(室)舒张末期容积

指标类型:

次要指标

Outcome:

Left atrial (ventricular) end-diastolic volume

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

左室射血分数

指标类型:

次要指标

Outcome:

left ventricular ejection fraction (LVEF)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

EHRA房颤症状评分

指标类型:

次要指标

Outcome:

The EHRA AF symptom score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 40 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究募集2024年9月至2025年至8月期间于北京小汤山医院门诊及住院就诊的符合心房颤动患者25例,所有受试者均签署知情同意书,并符合诊断标准、纳入标准、排除标准,剔除标准。

Randomization Procedure (please state who generates the random number sequence and by what method):

Twenty-five patients with atrial fibrillation in Beijing Xiaotangshan Hospital from September 2024 to August 2025 were enrolled in this study. All subjects signed the informed consent, and met the diagnostic criteria, inclusion criteria, exclusion criteria, and exclusion criteria.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Visit figshare.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

knowledge.figshare.com

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case record form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-11-28 16:34:48